Zincon Indicator Method for Bioavailable Zinc Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining the bioavailability of zinc (II) ions from oral care compositions, such as toothpastes, are complex and do not differentiate between therapeutically-active and inactive bound zinc, requiring a rapid and simple method to estimate the delivery of therapeutically-active zinc.
Innovation Solution
An in vitro method using a biorelevant substrate and zincon as an indicator, where the substrate is contacted with the oral care composition, separated, and then reacted with zincon under specific conditions to determine light absorbance, allowing for the estimation of zinc delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If atomic absorption spectroscopy or mass spectrometry is used to measure zinc, then quantitative determination of absorbed zinc is achieved, but the methods do not discriminate between therapeutically-active zinc ions and inactive bound zinc, and relatively complex apparatus is required
Solution Approach 1:
The patent extracts and measures only the bioavailable fraction of zinc by using a biorelevant substrate that selectively binds only free zinc ions, separating this fraction from total zinc before measurement. This extraction approach allows simple measurement of the biologically active portion without needing complex separation apparatus.
Solution Approach 2:
The patent introduces a biorelevant substrate as an intermediary that selectively binds bioavailable zinc ions, serving as a mediator between the complex oral care composition and the simple colorimetric detection system. This intermediary enables discrimination between active and inactive zinc forms through a straightforward visual or spectrophotometric readout.
2Measurement precision
If atomic absorption spectroscopy or mass spectrometry is used to measure zinc, then quantitative determination of absorbed zinc is achieved, but relatively complex apparatus is required
Solution Approach 1:
The patent replaces complex mechanical and electronic measurement systems (AAS, ICP-MS) with a simple colorimetric chemical system. The biorelevant substrate forms a colored complex with zinc that can be measured visually or with basic spectrophotometry, eliminating the need for sophisticated instrumentation and simplifying operation.
3Quantity of substance
If conventional methods are used to measure zinc delivery, then total zinc quantity can be determined, but they do not differentiate between therapeutically-active and inactive bound zinc
Solution Approach 1:
The patent segments zinc measurement into distinct fractions: bioavailable zinc that binds to the biorelevant substrate and non-bioavailable zinc that remains unbound. This segmentation allows separate measurement and quantification of the therapeutically active portion, providing precise information about actual zinc delivery rather than just total zinc content.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a rapid and straightforward estimation of in vivo zinc delivery, correlating well with clinical studies and allowing for the ranking of oral care compositions based on their ability to deliver zinc, while being selective for free zinc (II) ions.
Implementation Method 1
contacting the biorelevant substrate with an indicator under conditions selected such that the indicator is capable of reacting with zinc (II) ions
Implementation Method 2
determining a light absorbance of the indicator
Data Source
AI summary
An in vitro method for determining the bioavailability of zinc (II) ions from an oral care composition comprises: providing a sample comprising, the oral care composition; contacting the sample with a biorelevant substrate, separating the biorelevant substrate from the sample, contacting the biorelevant substrate with an indicator under conditions selected such that the indicator is capable of reacting with zinc (II) ions, and determining a light absorbance of the indicator. The indicator is zincon or a salt thereof. The method is useful for estimating the ability of an oral care composition to deliver therapeutically-active zinc (II) ions to the oral cavity. Also provided is the use of zincon and a biorelevant substrate in vitro to determine the bioavailability of zinc (II) ions from an oral care composition comprising, a zinc source.